創世紀(300083.SZ):擬投建東莞創羣智能製造項目
格隆匯 8 月 24日丨創世紀(300083.SZ)公佈,公司控股孫公司東莞市創羣精密機械有限公司(“東莞創羣”)根據高端智能裝備業務需要,擬投資建設東莞創羣智能製造項目,公司擬為項目建設的項目貸款提供擔保。
鑑於公司高端智能裝備業務發展勢頭良好,產能缺口矛盾逐漸顯現,且目前主要生產場地為租賃取得,存在一定不確定性,公司擬在自有土地上投資建設東莞創羣智能製造項目,為未來產能搬遷與提升做準備。項目建設地點為東莞市沙田鎮,項目總投資額預計為18億元(分期投入)。
此外,項目實施主體東莞創羣擬向銀行等金融機構申請項目貸款綜合授信額度不超過10億元,公司及其下屬企業擬為該授信提供擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.